Hosted on MSN10mon
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo TherapyIn April, the FDA approved Anktiva plus BCG for BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The arrangement will result in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results